NCT06669637尚未招募不适用
Amplify EP Registry
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 1,100
- 主要终点
- Long term effectiveness
研究概览
简要总结
An observational, prospective, multi-center, non-randomized registry designed to obtain real world clinical experience with the TactiFlex Catheter Ablation system in the treatment of Atrial Fibrillation. Patient assessments will occur at pre procedure and procedure, and 1 year post ablation
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who, in the opinion of the investigator, are candidates for ablation to treat atrial fibrillation.
- •Plans to undergo an ablation procedure using the TactiFlex Ablation Catheter™, Sensor Enabled™ (TactiFlex SE) manufactured by Abbott.
- •De Novo or redo AF catheter ablation procedures.
- •Able and willing to participate in baseline and all follow up evaluations.
- •18 years of age or older.
排除标准
- •Enrolled in any other cardiac device clinical trial, investigational drug trial, or any other trial that may confound the results of the ablation procedure.
- •In the opinion of the investigator, any known contraindication to an ablation procedure or to any device or drug required for use during an ablation procedure as assessed by the investigator.
结局指标
主要结局
Long term effectiveness
时间窗: 12-month
defined as freedom from recurrence of AF/AT/AFL \>30 sec at 12-month follow-up
次要结局
- Acute success(at time of procedure)
- Acute safety(30 days)
- Long term safety(12 months)
研究者
相似试验
终止
不适用
Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial Fibrillation (DYNAMIC AF Registry)Atrial FibrillationNCT05242250Heart Rhythm Clinical and Research Solutions, LLC392
Unknown
不适用
AMBULATE Same Day Discharge RegistryVascular ClosureNCT04203329Cardiva Medical, Inc.700
已完成
不适用
A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.Multiple MyelomaNCT02164955Celgene775
招募中
不适用
A Registry of Participants with Prostate Cancer in AsiaCTRI/2018/01/011570Janssen Research Development LLC
已完成
不适用
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical PracticeS. Aureus Bloodstream InfectionNCT01212601AstraZeneca203